SPHK1 and cancer: In addition, investigations in cancer and non-cancer cells demonstrate that increased SPHK1 is associated with increased production of S1P in cells and S1P promotes cell proliferation, angiogenesis and inhibits cell death all of which could promote cell survival following cytotoxic drug insult and hence induce resistance [22–29, 37, 40, 41].